{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:12:20Z","timestamp":1761808340939,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.hrthm.2020.01.022","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T19:47:17Z","timestamp":1580500037000},"page":"984-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population"],"prefix":"10.1016","volume":"17","author":[{"given":"Stephanie F.","family":"Chandler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Whitehill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios J.","family":"Bezzerides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth S.","family":"DeWitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"Triedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward P.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas Y.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.01.022_bib1","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(90)90196-8","article-title":"Pharmacology, pharmacodynamics and pharmacokinetics of sotalol","volume":"65","author":"Antonaccio","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib2","doi-asserted-by":"crossref","first-page":"84A","DOI":"10.1016\/0002-9149(90)90209-J","article-title":"Expanding clinical role of unique class III antiarrhythmic effects of sotalol","volume":"65","author":"Singh","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00246-005-1126-x","article-title":"Medications used to manage supraventricular tachycardia in the infant a North American survey","volume":"27","author":"Wong","year":"2006","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s002469900104","article-title":"New antiarrhythmic drug in pediatric use: sotalol","volume":"18","author":"Pfammatter","year":"1997","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0735-1097(98)00189-2","article-title":"Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications","volume":"32","author":"Chung","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib6","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/europace\/eut153","article-title":"QT variability during initial exposure to sotalol: experience based on a large electronic medical record","volume":"15","author":"Weeke","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.01.022_bib7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00246-011-0010-0","article-title":"High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias","volume":"32","author":"Knudson","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib8","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1253\/circj.CJ-08-0194","article-title":"Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease","volume":"72","author":"Miyazaki","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2020.01.022_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-8703(95)90079-9","article-title":"Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome","volume":"130","author":"Tanel","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2020.01.022_bib11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/0735-1097(95)00268-3","article-title":"Efficacy and proarrhythmia of oral sotalol in pediatric patients","volume":"26","author":"Pfammatter","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib12","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1540-8159.1991.tb02816.x","article-title":"Efficacy and safety of oral sotalol in early infancy","volume":"14","author":"Tipple","year":"1991","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0002-9149(92)90500-X","article-title":"Effectiveness of oral sotalol for treatment of pediatric arrhythmias","volume":"69","author":"Maragn\u00e8s","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1651-2227.1988.tb10622.x","article-title":"Oral sotalol in neonatal supraventricular tachycardia","volume":"77","author":"Bowman","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.hrthm.2020.01.022_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/pace.12586","article-title":"Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation","volume":"38","author":"Agusala","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199409223311207","article-title":"Risks and benefits of antiarrhythmic therapy","volume":"331","author":"Wood","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.01.022_bib17","doi-asserted-by":"crossref","first-page":"74A","DOI":"10.1016\/0002-9149(90)90207-H","article-title":"Clinical safety profile of sotalol in patients with arrhythmias","volume":"65","author":"Soyka","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.022_bib18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.117.029590","article-title":"Atrial fibrillation burden in young patients with congenital heart disease","volume":"137","author":"Mandalenakis","year":"2018","journal-title":"Circulation"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120300746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120300746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:51:18Z","timestamp":1761547878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527120300746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1547527120300746"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.01.022","relation":{},"ISSN":["1547-5271"],"issn-type":[{"type":"print","value":"1547-5271"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}